APLLTD

Alembic Pharmaceuticals Share PriceAlembic Pharmaceuticals

₹496.35
27.7 (5.91%)
  • Advice
  • Hold
As on 31 March, 2023 | 20:38 BSE: 533573 NSE: APLLTD

Alembic Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Alembic Pharmaceuticals

Start SIP

Alembic Pharmaceuticals Share Price

  • Over 1 Month -2.92%
  • Over 3 Month -13.36%
  • Over 6 Month -17.91%
  • Over 1 Year -33.07%

Alembic Pharmaceuticals Key Statistics

P/E Ratio 43.4
PEG Ratio -0.6
Market Cap Cr 9,756
Price to Book Ratio 1.9
EPS 27.5
Dividend 2
Relative Strength Index 49.41
Money Flow Index 61.8
MACD Signal -10.14
Average True Range 16.58

Alembic Pharmaceuticals Investment Rating

  • Master Rating:
  • Alembic Pharmaceuticals has an operating revenue of Rs. 5,661.91 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 12% is healthy, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Alembic Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,3101,3541,1601,304
Operating Expenses Qtr Cr 1,0861,1091,0341,013
Operating Profit Qtr Cr 224245127291
Depreciation Qtr Cr 66674646
Interest Qtr Cr 151296
Tax Qtr Cr 252100
Net Profit Qtr Cr 11914672251

Alembic Pharmaceuticals Technicals

EMA & SMA

Current Price
₹496.35
27.7 (5.91%)
  • Bullish Moving Average
  • ___
  • 7
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • 492.81
  • 50 Day
  • 513.6
  • 100 Day
  • 544.32
  • 200 Day
  • 595.68
  • 20 Day
  • 492.36
  • 50 Day
  • 513.93
  • 100 Day
  • 553.04
  • 200 Day
  • 603.98

Alembic Pharmaceuticals Resistance and Support

PIVOT
₹471.25
Resistance
First Resistance 480.2
Second Resistance 491.75
Third Resistance 500.7
RSI 49.41
MFI 61.8
MACD Single Line -10.14
MACD -9.14
Support
First Resistance 459.7
Second Resistance 450.75
Third Resistance 439.2

Alembic Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,160,304 11,254,949 9.7
Week 434,367 12,453,302 28.67
1 Month 187,094 6,318,147 33.77
6 Month 157,938 7,745,288 49.04

Alembic Pharmaceuticals Result Highlights

Alembic Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5035.41 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2022. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.
Market Cap 9,687
Sales 5,129
Shares in Float 5.90
No of funds 164
Yield 2.13
Book Value 1.83
U/D Vol ratio 1.1
LTDebt / Equity 4
Alpha -0.18
Beta 0.5

Alembic Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 69.61%69.61%69.61%
Mutual Funds 5.87%5.36%5.01%
Insurance Companies 6.6%7.03%7.01%
Foreign Portfolio Investors 4.99%5.32%5.94%
Financial Institutions/ Banks 0.04%0.04%0.04%
Individual Investors 9.21%9.12%8.91%
Others 3.68%3.52%3.48%

Alembic Pharmaceuticals Management

Name Designation
Mr. Chirayu Amin Chairman & CEO
Mr. Pranav Amin Managing Director
Mr. Shaunak Amin Managing Director
Mr. R K Baheti Director - Finance & CFO
Mr. K G Ramanathan Independent Director
Mr. Pranav Parikh Independent Director
Mr. Paresh Saraiya Independent Director
Dr. Archana Hingorani Independent Director
Mr. Ashok Barat Independent Director

Alembic Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alembic Pharmaceuticals MF Shareholding

Name Amount(cr)
HDFC Mid-Cap Opportunities Fund Growth 35010
DSP Midcap Fund Growth 13213
DSP Tax Saver Fund Regular Plan Growth 10129
Kotak Small Cap Growth 8618
DSP Top 100 Equity Fund Regular Plan Growth 2606

Alembic Pharmaceuticals FAQs

What is Share Price of Alembic Pharmaceuticals ?

Alembic Pharmaceuticals share price is ₹496 As on 31 March, 2023 | 20:24

What is the Market Cap of Alembic Pharmaceuticals ?

The Market Cap of Alembic Pharmaceuticals is ₹9756.4 Cr As on 31 March, 2023 | 20:24

What is the P/E ratio of Alembic Pharmaceuticals ?

The P/E ratio of Alembic Pharmaceuticals is 43.4 As on 31 March, 2023 | 20:24

What is the PB ratio of Alembic Pharmaceuticals ?

The PB ratio of Alembic Pharmaceuticals is 1.9 As on 31 March, 2023 | 20:24

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number